10-KPeriod: FY2023

NORTHROP GRUMMAN CORP /DE/ Annual Report, Year Ended Dec 31, 2023

Filed January 25, 2024For Securities:NOC

Summary

Northrop Grumman Corporation (NOC) reported a significant increase in sales for the fiscal year ended December 31, 2023, with total sales reaching $39.29 billion, a 7% increase year-over-year. This growth was driven by strong demand across all four operating segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. However, the company's operating income saw a substantial decrease of 30% to $2.54 billion, primarily due to a $1.56 billion charge related to the B-21 Raider program's low-rate initial production phase. This charge, stemming from revised assumptions on funding mitigation for macroeconomic disruptions and higher projected manufacturing costs, significantly impacted the Aeronautics Systems segment, resulting in an operating loss for that segment. Despite the operating income decline, the company's backlog of future sales obligations grew to $84.2 billion, indicating continued demand and strong program execution expected in the coming periods. Northrop Grumman continues to navigate macroeconomic challenges, including inflation and supply chain disruptions, which have influenced cost projections on key programs. The company's strategic focus on national security priorities and advanced technological capabilities positions it to capitalize on the evolving global defense landscape, though investors should remain mindful of program-specific cost pressures and government funding dynamics.

Financial Statements
Beta
Revenue$39.29B
R&D Expenses$1.20B
Operating Expenses$36.75B
Operating Income$2.54B
Net Income$2.06B
EPS (Basic)$13.57
EPS (Diluted)$13.53
Shares Outstanding (Basic)151.50M
Shares Outstanding (Diluted)152.00M

Key Highlights

  • 1Total sales increased by 7% to $39.29 billion in FY2023, driven by demand across all segments.
  • 2Operating income decreased by 30% to $2.54 billion, largely impacted by a $1.56 billion charge on the B-21 Raider program.
  • 3The B-21 charge negatively affected the Aeronautics Systems segment, resulting in an operating loss of $473 million for the segment.
  • 4Backlog increased by 7% to $84.2 billion, indicating a strong pipeline of future business.
  • 5Space Systems segment showed robust sales growth of 14% and a 5% increase in operating income.
  • 6The company reported diluted earnings per share of $13.53, a significant decrease from $31.47 in the prior year, primarily due to the B-21 charge and other factors.
  • 7Northrop Grumman continues to manage macroeconomic challenges like inflation and supply chain issues, which are influencing program cost estimates.

Frequently Asked Questions

The primary reason for the substantial decrease in operating income was a $1.56 billion charge recognized in the fourth quarter of 2023 related to the B-21 Raider program's low-rate initial production (LRIP) phase. This charge was due to revised assumptions regarding funding to mitigate macroeconomic disruptions and higher projected manufacturing costs.

The B-21 charge significantly impacted the Aeronautics Systems segment, leading to an operating loss of $473 million for the segment in 2023 and a negative operating margin rate of (4.4)%. This was a sharp contrast to the segment's positive operating income and 10.6% margin in the prior year.

Northrop Grumman's total backlog increased by 7% to $84.2 billion as of December 31, 2023. The company expects to recognize approximately 40% of this backlog over the next 12 months and 65% over the next 24 months, indicating a strong demand pipeline for its products and services.

Northrop Grumman is actively working to mitigate the impact of macroeconomic challenges. This includes incorporating management's best estimates of inflation and supply chain disruptions into contract estimates at completion (EACs), seeking economic price adjustment clauses, and seeking equitable adjustments on contracts. However, these challenges have impacted cost projections, particularly on fixed-price contracts and programs like the B-21 LRIP phase.